STOCK TITAN

Precipio Inc SEC Filings

PRPO Nasdaq

Welcome to our dedicated page for Precipio SEC filings (Ticker: PRPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Looking for the story behind Precipio’s cancer-diagnostic breakthroughs without wading through hundreds of technical pages? Start here. Investors often begin with the Precipio quarterly earnings report 10-Q filing to gauge test-volume growth and reimbursement trends, then scan 8-K updates for FDA milestones or new academic partnerships.

Our platform delivers each SEC document the moment it appears on EDGAR and adds AI-powered summaries that translate complex laboratory terminology into plain English. Whether you need Precipio insider trading Form 4 transactions in real time, a concise view of R&D spending hidden deep in the annual report, or a quick comparison of segment revenues across filings, Stock Titan surfaces it instantly.

Use cases:

  • Track executive stock sales with the phrase-matched feed “Precipio executive stock transactions Form 4.”
  • Review pipeline progress—our AI highlights every HemeScreen or IV-Cell mention across 10-K and 10-Q filings.
  • Assess reimbursement risk via keyword tagging in the proxy statement and risk-factor sections.

The coverage is complete: 10-K annual reports, proxy statements on executive compensation, 8-K material events explained, and every Precipio earnings report filing analysis—all simplified. Understanding Precipio SEC documents with AI means less time decoding regulatory language and more time making decisions.

Rhea-AI Summary

Precipio, Inc. (PRPO) reported an insider stock transaction by a director. On October 15, 2025, the director acquired 746 shares of common stock at $17.58 per share. The grant was issued as consideration in lieu of cash compensation for service on the Board of Directors for Q3-25.

Following this transaction, the director beneficially owns 53,572 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Precipio, Inc. (PRPO) reported an insider transaction by a director. On 10/15/2025, the director acquired 568 shares of common stock in a transaction coded “A,” reflecting a grant in lieu of cash compensation for Board service for Q3‑25. The filing lists a price of $17.58.

Following this grant, the director’s beneficial ownership stands at 15,708 shares, held directly. This is a routine equity compensation event and does not indicate a public offering or company-level capital raise.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Precipio (PRPO): A company director reported acquiring 597 shares of common stock on October 15, 2025 at $17.58 per share. The shares were granted as equity in lieu of cash compensation for service on the Board for Q3-25.

Following the transaction, the reporting person beneficially owns 15,247 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Precipio (PRPO) director Kathleen D. LaPorte reported acquiring 711 shares of common stock on October 15, 2025 at $17.58 per share. The grant was issued in lieu of cash compensation for service on the Board of Directors for Q3-25.

After this transaction, LaPorte directly owns 6,862 shares of Precipio common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Leviticus Partners LP reports beneficial ownership of 130,000 shares of Precipio, Inc. common stock, representing 8.0% of the class. The filing states the shares are held with sole voting and dispositive power and were acquired and are held in the ordinary course of business, not for the purpose of changing control of the issuer. The filing is signed by Adam M Hutt as Managing Member and dated 09/22/2025. No group affiliations, subsidiaries, or additional arrangements are disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Kathleen LaPorte, a director of Precipio, Inc. (PRPO), reported the sale of 6,152 shares of the issuer's common stock on 09/08/2025 at a weighted average price of $20.06 per share. After the reported disposals, she beneficially owned 6,151 shares. The shares were originally granted to Ms. LaPorte on 04/15/2024 as consideration in lieu of cash for board service covering Q1 2023 through Q1 2024; that grant was approved by the board under Rule 16b-3 and is exempt from Section 16(b). The Form 4 is signed by Ms. LaPorte on 09/10/2025. The filing notes the shares were sold in multiple transactions at prices ranging from $20.00 to $20.50.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Form 144 notice for Precipio, Inc. (PRPO): A holder plans to sell 6,152 shares of Common stock through Morgan Stanley Smith Barney, with an aggregate market value of $123,384.51. The shares represent part of 1,619,584 shares outstanding and the proposed approximate sale date is 09/08/2025.

The shares were acquired on 04/15/2024 as board compensation and paid as compensation. The filer reports no sales in the past three months and certifies no undisclosed material information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Precipio, Inc. reported net sales of $5.65 million for the three months ended June 30, 2025, up from $4.44 million a year earlier, led by service revenue of $5.005 million versus $3.909 million. Gross profit for the quarter was $2.43 million compared with $1.72 million in the prior year. The company recorded net income of $74 thousand in the quarter versus a $1.22 million loss in Q2 2024; for the six months it reported a net loss of $810 thousand compared with a $3.30 million loss a year earlier. A material contributor to quarterly other income was a recorded Employee Retention Credit of approximately $789 thousand.

The balance sheet shows total assets of $18.82 million, cash of $1.13 million and an accumulated deficit of $103.3 million. Management discloses substantial doubt about the company’s ability to continue as a going concern for the next twelve months absent additional revenue or financing. Material items disclosed include purchase commitments of approximately $2.2 million, a CHC temporary funding balance of about $0.6 million to be repaid through January 2026, and customer concentration with one customer representing ~27% of net sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
quarterly report

FAQ

What is the current stock price of Precipio (PRPO)?

The current stock price of Precipio (PRPO) is $18.24 as of October 20, 2025.

What is the market cap of Precipio (PRPO)?

The market cap of Precipio (PRPO) is approximately 27.9M.
Precipio Inc

Nasdaq:PRPO

PRPO Rankings

PRPO Stock Data

27.94M
1.41M
12.81%
5.75%
0.09%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
OMAHA